Topical 0.03% Atropine vs. 15% aluminum chloride in treating multiple eccrine hidrocystomas: a randomized single blind controlled study.

Background: Multiple eccrine hidrocystomas pose a significant treatment challenge due to their facial location and tendency to scar after traditional surgical and other destructive modalities.

Aims: To compare two frequently used non-destructive therapeutic modalities.

Materials And Methods: Thirty patients with multiple eccrine hidrocystomas were enrolled in the study.